Skip to main content

Leadership

2012 News Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
DateTitle  
12/28/12Emergent BioSolutions Secures Exclusive U.S. Commercial Rights to Next Generation Pandemic Influenza Vaccine Candidate Printer Friendly Version
12/03/12Emergent BioSolutions to Present at 31st Annual J.P. Morgan Healthcare ConferenceDownload PDFPrinter Friendly Version
11/19/12Emergent BioSolutions Appoints Robert G. Kramer as Chief Financial OfficerDownload PDFPrinter Friendly Version
11/12/12Emergent BioSolutions to Participate in Piper Jaffray’s 24th Annual Healthcare ConferenceDownload PDFPrinter Friendly Version
11/07/12Emergent BioSolutions Announces Presentation on Bispecific Protein Therapeutic at 24th Annual EORTC-NCI-AACR SymposiumDownload PDFPrinter Friendly Version
11/05/12Emergent BioSolutions Announces Acceptance of TRU-016 and Bispecific Abstracts for Presentation at 2012 American Society of Hematology Annual MeetingDownload PDFPrinter Friendly Version
11/01/12Emergent BioSolutions Announces Growth Plan Through 2015Download PDFPrinter Friendly Version
11/01/12Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2012Download PDFPrinter Friendly Version
10/31/12Emergent BioSolutions Initiates Phase 1b Study of TRU-016 in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic LeukemiaDownload PDFPrinter Friendly Version
10/09/12Emergent BioSolutions to Release Third Quarter 2012 Financial Results and Conduct a Conference Call on November 1, 2012Download PDFPrinter Friendly Version
10/04/12BARDA Exercises Contract Option as Emergent BioSolutions Achieves Significant Progress in rPA Anthrax Vaccine DevelopmentDownload PDFPrinter Friendly Version
08/28/12Emergent BioSolutions to Present at ThinkEquity’s 9th Annual Growth ConferenceDownload PDFPrinter Friendly Version
08/08/12Emergent BioSolutions to Present at Wedbush 2012 Life Sciences Management Access ConferenceDownload PDFPrinter Friendly Version
08/02/12Emergent BioSolutions Reports Financial Results for Second Quarter and First Six Months of 2012Download PDFPrinter Friendly Version
07/09/12Emergent BioSolutions to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 2, 2012Download PDFPrinter Friendly Version
06/18/12BARDA and Emergent BioSolutions Partner to Establish Center for Innovation in Advanced Development and ManufacturingDownload PDFPrinter Friendly Version
06/04/12Emergent BioSolutions Secures Additional Funding from BARDA to Pursue Post-Exposure Prophylaxis Indication for BioThraxDownload PDFPrinter Friendly Version
05/22/12Emergent BioSolutions to Present at Jefferies 2012 Global Healthcare ConferenceDownload PDFPrinter Friendly Version
05/21/12Emergent BioSolutions Announces Stock Repurchase ProgramDownload PDFPrinter Friendly Version
05/17/12Emergent BioSolutions Receives FDA Approval for BioThrax Administered Intramuscularly in a Three-Dose Primary Series Followed by Booster DosesDownload PDFPrinter Friendly Version
05/10/12Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday, May 17, 2012 at 9:00 AM Eastern; Webcast Will Be AvailableDownload PDFPrinter Friendly Version
05/03/12Emergent BioSolutions Reports Financial Results for First Quarter 2012Download PDFPrinter Friendly Version
04/26/12Emergent BioSolutions Executive Chairman Fuad El-Hibri Named Tech Council of Maryland's Executive of the YearDownload PDFPrinter Friendly Version
04/26/12NATO Emerging Security Challenges Division Partners with Emergent BioSolutions to Host Biopreparedness Workshop at the Counter Terror Expo in LondonDownload PDFPrinter Friendly Version
04/12/12Emergent BioSolutions to Release First Quarter 2012 Financial Results and Conduct a Conference Call on May 3, 2012Download PDFPrinter Friendly Version
03/22/12Emergent BioSolutions Receives NIAID Grant to Support Tuberculosis Vaccine CandidateDownload PDFPrinter Friendly Version
03/08/12Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2011Download PDFPrinter Friendly Version
02/20/12Emergent BioSolutions to Present at Cowen and Company Health Care ConferenceDownload PDFPrinter Friendly Version
01/30/12Emergent BioSolutions to Release Fourth Quarter and Full Year 2011 Financial Results and Conduct a Conference Call on March 8, 2012Download PDFPrinter Friendly Version
01/09/12Emergent BioSolutions Provides Preliminary 2011 Financial Results and Provides Guidance for 2012Download PDFPrinter Friendly Version